Everolimus (RAD001) in Elderly Patients With Acute Myeloid Leukemia

Summary

The main goal of this study is to assess the safety and tolerability of RAD001 in combination with low-dose cytarabine in acute myeloid leukemia patients unfit for intensive chemotherapy. The secondary goals are to investigate the likely causes of drug response or failure.

Timeline

Start

2010-02

Primary completion

2013-07

Completion

2014-01

Drugs

Indications